Synthetic HLA-A2 derived peptides are recognized and presented in renal graft recipients

Human Immunology

Volumn 61, Issue 12, 2000, Pages 1363-1369

  Stegmann, Sandra ^a   Müller, Angelika ^a   Zavazava, Nicholas ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Allopeptides; HLA A2; Indirect presentation; Rejection; Transplantation

Indexed keywords

CD4 ANTIGEN; HLA A2 ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLOIMMUNITY; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOINCOMPATIBILITY; HUMAN; HUMAN CELL; KIDNEY GRAFT; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY TESTING; HLA-A2 ANTIGEN; HUMANS; HYBRIDOMAS; IMMUNOSUPPRESSIVE AGENTS; K562 CELLS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POSTOPERATIVE PERIOD; TUMOR CELLS, CULTURED;

EID: 0034488053     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00215-9     Document Type: Article

References (20)

1. The molecular basis of alloreactivity
2. Alloreactivity: Allogeneic presentation of endogeneous peptide or direct recognition of MHC polymorphism? A review
3. Contribution of direct and indirect recognition pathways to T cell alloreactivity
4. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses
5. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation
6. Limited T cell response to donor MHC peptides during allograft rejection
7. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides
8. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection
9. T cell recognition of allopeptides in context of syngeneic MHC
10. Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection
11. Oral feeding of an immunodominant MHC-donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination
12. Mechanisms of T cell recognition of alloantigen
13. Indirect recognition of donor HLA-DR peptides in organ allograft rejection
14. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome
15. New strategies for early diagnosis of heart allograft rejection
16. Evidence of indirect allorecognition in long-term human renal transplantation
17. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction
18. Different in vivo tolerogenicity of MHC class I peptides
19. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) all-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide
20. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides